Last reviewed · How we verify

NCT02884440: TAP ALIF

Transverse Abdominis Plane Block for Anterior Approach Spine Surgery

Completed Phase 2 Last updated 24 May 2023
What this trial tests

Phase 2 trial testing TAP block ropivacaine in Spine Surgery in 43 participants. Completed in 25 May 2019.

Timeline
7 November 2016
Primary endpoint
25 May 2019
25 May 2019

Quick facts

Lead sponsorRennes University Hospital
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment43
Start date7 November 2016
Primary completion25 May 2019
Estimated completion25 May 2019
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Rennes University Hospital

Who can join

18 and older, any sex, with Spine Surgery or Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Therapeutic, prospective, randomized, double blind, placebo-controlled, in intention to treat, monocentric study to evaluate the analgesic efficacy of a bilateral TAP block after spine surgery with 24 hours morphine consumption

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Spine Surgery

Currently open trials in the same condition.

Other Rennes University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02884440.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing